Chonnam National University Hospital Recruiting Beneficiary Companies for 'Senior Cosmedicare Technology Commercialization Support' View original image

[Asia Economy Honam Reporting Headquarters Reporter Yoon Jamin] Jeonnam National University Hospital (Director Ahn Younggeun) announced on the 31st that it is recruiting beneficiary companies for the ‘2022 Senior Cosmedical Care Technology Commercialization Support’ to foster cosmedical care, a high value-added new concept industry.


Applications can be submitted through the Jeonnam National University Hospital Senior Cosmedical Care Demonstration Center website, the Gwangju Technopark Foundation website, or by mail until April 15.


The recruitment target is companies registered nationwide as responsible sellers related to cosmedical care (cosmetics) manufacturing.


The cosmedical care industry is a compound word combining Cosmetic, Medical, and Care (beauty devices).


It is a high value-added new concept industry that integrates high-functional cosmetics combined with dermatology, beauty device manufacturing, and beauty services.


This beneficiary company support has been prepared since 2020 to contribute to revitalizing the regional industry by laying the foundation for Gwangju city’s future growth engine industry and strengthening corporate attraction and competitiveness.


The support program includes a total of nine areas such as ▲efficacy evaluation ▲prototype production ▲usability evaluation ▲joint marketing support, and the total support scale is 674 million KRW.


Kim Sungjin, head of the Senior Cosmedical Care Demonstration Center, said, “Since 2020, we have supported 30 companies, and last year 43 companies, with the number of beneficiary companies increasing every year. We will take the lead in laying the foundation for the growth of cosmedical care companies and strive to attract promising cosmetics-related companies to Gwangju.”



Meanwhile, the Senior Cosmedical Care Demonstration Center supports the technology commercialization of cosmedical care products through infrastructure construction such as a hospital-linked clinical efficacy evaluation system (Jeonnam National University Hospital) and excellent cosmetics production facilities (Gwangju Technopark).


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing